

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sex differentiation (GO:0007548) | 8.09680255 |
| 2 | negative regulation of type 2 immune response (GO:0002829) | 7.92596372 |
| 3 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 7.90393364 |
| 4 | tachykinin receptor signaling pathway (GO:0007217) | 7.41130013 |
| 5 | regulation of establishment of cell polarity (GO:2000114) | 7.06729155 |
| 6 | activation of MAPKKK activity (GO:0000185) | 6.94682956 |
| 7 | alternative mRNA splicing, via spliceosome (GO:0000380) | 6.88207644 |
| 8 | cytoplasmic mRNA processing body assembly (GO:0033962) | 6.86585896 |
| 9 | regulation of MHC class I biosynthetic process (GO:0045343) | 6.70957183 |
| 10 | negative regulation of multicellular organism growth (GO:0040015) | 6.67945396 |
| 11 | regulation of uterine smooth muscle contraction (GO:0070472) | 5.85657701 |
| 12 | hyperosmotic salinity response (GO:0042538) | 5.75058589 |
| 13 | cholesterol catabolic process (GO:0006707) | 5.71284994 |
| 14 | sterol catabolic process (GO:0016127) | 5.71284994 |
| 15 | regulation of metalloenzyme activity (GO:0048552) | 5.70454962 |
| 16 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 5.67384074 |
| 17 | cerebellar Purkinje cell differentiation (GO:0021702) | 5.58940738 |
| 18 | synaptic transmission, cholinergic (GO:0007271) | 5.41730026 |
| 19 | stress granule assembly (GO:0034063) | 5.41407646 |
| 20 | primary amino compound metabolic process (GO:1901160) | 5.39862480 |
| 21 | regulation of dopamine metabolic process (GO:0042053) | 5.17255043 |
| 22 | regulation of catecholamine metabolic process (GO:0042069) | 5.17255043 |
| 23 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 5.14090640 |
| 24 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 5.05339295 |
| 25 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 5.01020685 |
| 26 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 5.01020685 |
| 27 | serotonin metabolic process (GO:0042428) | 4.97077018 |
| 28 | chaperone-mediated protein complex assembly (GO:0051131) | 4.88283416 |
| 29 | kynurenine metabolic process (GO:0070189) | 4.71110633 |
| 30 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 4.69079655 |
| 31 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 4.69079655 |
| 32 | RNA destabilization (GO:0050779) | 4.68093276 |
| 33 | positive regulation of vasculogenesis (GO:2001214) | 4.65407795 |
| 34 | tryptophan metabolic process (GO:0006568) | 4.63190145 |
| 35 | regulation of interleukin-13 production (GO:0032656) | 4.48629841 |
| 36 | regulation of glucocorticoid secretion (GO:2000849) | 4.17036334 |
| 37 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 4.16984813 |
| 38 | behavioral response to nicotine (GO:0035095) | 4.09974053 |
| 39 | negative regulation of interleukin-1 beta production (GO:0032691) | 4.05521944 |
| 40 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 3.96506876 |
| 41 | ADP metabolic process (GO:0046031) | 3.95480024 |
| 42 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.90797014 |
| 43 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 3.81713480 |
| 44 | dopamine biosynthetic process (GO:0042416) | 3.81649929 |
| 45 | regulation of feeding behavior (GO:0060259) | 3.80669584 |
| 46 | tryptophan catabolic process (GO:0006569) | 3.77857613 |
| 47 | indole-containing compound catabolic process (GO:0042436) | 3.77857613 |
| 48 | indolalkylamine catabolic process (GO:0046218) | 3.77857613 |
| 49 | regulation of interleukin-5 production (GO:0032674) | 3.74727607 |
| 50 | positive regulation of mRNA catabolic process (GO:0061014) | 3.68708840 |
| 51 | positive regulation of mRNA 3-end processing (GO:0031442) | 3.68456343 |
| 52 | neuronal action potential propagation (GO:0019227) | 3.67952603 |
| 53 | lipid particle organization (GO:0034389) | 3.66905456 |
| 54 | indole-containing compound metabolic process (GO:0042430) | 3.54434437 |
| 55 | catecholamine biosynthetic process (GO:0042423) | 3.52240007 |
| 56 | catechol-containing compound biosynthetic process (GO:0009713) | 3.52240007 |
| 57 | regulation of vasculogenesis (GO:2001212) | 3.51618010 |
| 58 | negative regulation of interleukin-1 production (GO:0032692) | 3.51122596 |
| 59 | dopamine transport (GO:0015872) | 3.49428133 |
| 60 | embryonic hemopoiesis (GO:0035162) | 3.49149991 |
| 61 | L-fucose catabolic process (GO:0042355) | 3.47096624 |
| 62 | fucose catabolic process (GO:0019317) | 3.47096624 |
| 63 | L-fucose metabolic process (GO:0042354) | 3.47096624 |
| 64 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.41335499 |
| 65 | short-term memory (GO:0007614) | 3.37448729 |
| 66 | NAD biosynthetic process (GO:0009435) | 3.34665156 |
| 67 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 3.33335435 |
| 68 | positive regulation of dendritic spine development (GO:0060999) | 3.33263604 |
| 69 | regulation of corticosteroid hormone secretion (GO:2000846) | 3.31153849 |
| 70 | seminiferous tubule development (GO:0072520) | 3.29296882 |
| 71 | negative regulation of endothelial cell proliferation (GO:0001937) | 3.26538840 |
| 72 | central nervous system neuron axonogenesis (GO:0021955) | 3.23995219 |
| 73 | regulation of mRNA catabolic process (GO:0061013) | 3.19618950 |
| 74 | negative regulation of mast cell activation (GO:0033004) | 3.18698729 |
| 75 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.17266949 |
| 76 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.12646240 |
| 77 | glycerophospholipid catabolic process (GO:0046475) | 3.09629594 |
| 78 | negative regulation of macroautophagy (GO:0016242) | 3.07218584 |
| 79 | steroid catabolic process (GO:0006706) | 3.05258324 |
| 80 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.02144975 |
| 81 | response to cocaine (GO:0042220) | 3.01571202 |
| 82 | peptidyl-threonine dephosphorylation (GO:0035970) | 3.01354616 |
| 83 | indolalkylamine metabolic process (GO:0006586) | 3.01203855 |
| 84 | nucleoside diphosphate catabolic process (GO:0009134) | 2.98191142 |
| 85 | positive regulation of heart rate (GO:0010460) | 2.97388204 |
| 86 | histone H3-K4 trimethylation (GO:0080182) | 2.94418596 |
| 87 | regulation of mRNA 3-end processing (GO:0031440) | 2.93020514 |
| 88 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.91632166 |
| 89 | bile acid biosynthetic process (GO:0006699) | 2.88094375 |
| 90 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 2.82664246 |
| 91 | regulation of translational elongation (GO:0006448) | 2.79823716 |
| 92 | L-methionine salvage (GO:0071267) | 2.74121947 |
| 93 | L-methionine biosynthetic process (GO:0071265) | 2.74121947 |
| 94 | amino acid salvage (GO:0043102) | 2.74121947 |
| 95 | protein autoprocessing (GO:0016540) | 2.70771329 |
| 96 | lipid translocation (GO:0034204) | 2.70613728 |
| 97 | phospholipid translocation (GO:0045332) | 2.70613728 |
| 98 | regulation of gene silencing by miRNA (GO:0060964) | 2.70020943 |
| 99 | adaptation of signaling pathway (GO:0023058) | 13.8200263 |
| 100 | regulation of memory T cell differentiation (GO:0043380) | 10.1822620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 6.52769049 |
| 2 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 5.94148507 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 5.07968727 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 4.16599771 |
| 5 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 4.09624090 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.29862520 |
| 7 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.12537864 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.06831349 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.69416522 |
| 10 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.39844077 |
| 11 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.34160577 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.19762467 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.14063264 |
| 14 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.93723761 |
| 15 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.92959123 |
| 16 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.86443196 |
| 17 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.84161335 |
| 18 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.83972456 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.76015323 |
| 20 | FUS_26573619_Chip-Seq_HEK293_Human | 1.75537340 |
| 21 | TP53_16413492_ChIP-PET_HCT116_Human | 1.71933256 |
| 22 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.70808243 |
| 23 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.64595891 |
| 24 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.64542865 |
| 25 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.64542865 |
| 26 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.63924665 |
| 27 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.60170539 |
| 28 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.59231379 |
| 29 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.56362940 |
| 30 | TBL1_22424771_ChIP-Seq_293T_Human | 1.55250777 |
| 31 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.53755369 |
| 32 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.50757688 |
| 33 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.49467511 |
| 34 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.48393361 |
| 35 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.48372910 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.48315694 |
| 37 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.46270260 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45030472 |
| 39 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43906120 |
| 40 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.43906120 |
| 41 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.42641004 |
| 42 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.42137293 |
| 43 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.40436857 |
| 44 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.37135438 |
| 45 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35004367 |
| 46 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.32870495 |
| 47 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.30644778 |
| 48 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.30064347 |
| 49 | STAT3_23295773_ChIP-Seq_U87_Human | 1.29965206 |
| 50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29135308 |
| 51 | NFYB_21822215_ChIP-Seq_K562_Human | 1.26672642 |
| 52 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.26136735 |
| 53 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.25874499 |
| 54 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.21771213 |
| 55 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.21386220 |
| 56 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21017128 |
| 57 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.17406539 |
| 58 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16525985 |
| 59 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16514365 |
| 60 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.13078621 |
| 61 | NFYA_21822215_ChIP-Seq_K562_Human | 1.09199100 |
| 62 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08845269 |
| 63 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.07990332 |
| 64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.06557581 |
| 65 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.05899867 |
| 66 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.04650672 |
| 67 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.04432030 |
| 68 | P300_19829295_ChIP-Seq_ESCs_Human | 1.03578746 |
| 69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.03571583 |
| 70 | MYB_26560356_Chip-Seq_TH2_Human | 1.03093866 |
| 71 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02694783 |
| 72 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01595257 |
| 73 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.01306793 |
| 74 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.00730956 |
| 75 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99676459 |
| 76 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.99505913 |
| 77 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.99505913 |
| 78 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.97588937 |
| 79 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96790185 |
| 80 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.95678196 |
| 81 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.95214895 |
| 82 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95072773 |
| 83 | KDM2B_26808549_Chip-Seq_REH_Human | 0.94982744 |
| 84 | NCOR_22424771_ChIP-Seq_293T_Human | 0.94751577 |
| 85 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.94709659 |
| 86 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.94506235 |
| 87 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91965728 |
| 88 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.91413664 |
| 89 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.90825404 |
| 90 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89763982 |
| 91 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.88583793 |
| 92 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.88191646 |
| 93 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.88070691 |
| 94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88031112 |
| 95 | TCF4_23295773_ChIP-Seq_U87_Human | 0.87394253 |
| 96 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.87251270 |
| 97 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.86967438 |
| 98 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.85926437 |
| 99 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.84709354 |
| 100 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.84550630 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 7.88772687 |
| 2 | MP0009697_abnormal_copulation | 3.63496519 |
| 3 | MP0003252_abnormal_bile_duct | 3.44032280 |
| 4 | MP0002138_abnormal_hepatobiliary_system | 3.29897931 |
| 5 | MP0001986_abnormal_taste_sensitivity | 3.20122463 |
| 6 | MP0005171_absent_coat_pigmentation | 2.98386818 |
| 7 | MP0001968_abnormal_touch/_nociception | 2.96226417 |
| 8 | MP0002736_abnormal_nociception_after | 2.79905953 |
| 9 | MP0000371_diluted_coat_color | 2.58661552 |
| 10 | MP0003011_delayed_dark_adaptation | 2.49485265 |
| 11 | MP0009745_abnormal_behavioral_response | 2.47981421 |
| 12 | MP0003787_abnormal_imprinting | 2.38395236 |
| 13 | MP0001529_abnormal_vocalization | 2.09500934 |
| 14 | MP0000383_abnormal_hair_follicle | 2.07361995 |
| 15 | MP0004147_increased_porphyrin_level | 1.99881521 |
| 16 | MP0003195_calcinosis | 1.94882748 |
| 17 | MP0002009_preneoplasia | 1.93080664 |
| 18 | MP0001905_abnormal_dopamine_level | 1.82860791 |
| 19 | MP0005386_behavior/neurological_phenoty | 1.66447162 |
| 20 | MP0004924_abnormal_behavior | 1.66447162 |
| 21 | MP0003172_abnormal_lysosome_physiology | 1.58274349 |
| 22 | MP0004133_heterotaxia | 1.52426871 |
| 23 | MP0010678_abnormal_skin_adnexa | 1.47202137 |
| 24 | MP0001879_abnormal_lymphatic_vessel | 1.47119771 |
| 25 | MP0001501_abnormal_sleep_pattern | 1.43216294 |
| 26 | MP0002837_dystrophic_cardiac_calcinosis | 1.41380863 |
| 27 | MP0000372_irregular_coat_pigmentation | 1.38422804 |
| 28 | MP0002693_abnormal_pancreas_physiology | 1.38133040 |
| 29 | MP0008057_abnormal_DNA_replication | 1.37677975 |
| 30 | MP0000358_abnormal_cell_content/ | 1.34094867 |
| 31 | MP0006072_abnormal_retinal_apoptosis | 1.31723623 |
| 32 | MP0003880_abnormal_central_pattern | 1.31612382 |
| 33 | MP0001440_abnormal_grooming_behavior | 1.22974481 |
| 34 | MP0003186_abnormal_redox_activity | 1.22910283 |
| 35 | MP0003943_abnormal_hepatobiliary_system | 1.22899384 |
| 36 | MP0002168_other_aberrant_phenotype | 1.18096416 |
| 37 | MP0002075_abnormal_coat/hair_pigmentati | 1.17675004 |
| 38 | MP0005083_abnormal_biliary_tract | 1.17404187 |
| 39 | MP0002572_abnormal_emotion/affect_behav | 1.17312931 |
| 40 | MP0002272_abnormal_nervous_system | 1.14877003 |
| 41 | MP0004130_abnormal_muscle_cell | 1.13495100 |
| 42 | MP0003656_abnormal_erythrocyte_physiolo | 1.13429454 |
| 43 | MP0006035_abnormal_mitochondrial_morpho | 1.12278405 |
| 44 | MP0005253_abnormal_eye_physiology | 1.11043162 |
| 45 | MP0005220_abnormal_exocrine_pancreas | 1.08930664 |
| 46 | MP0004859_abnormal_synaptic_plasticity | 1.08576956 |
| 47 | MP0002751_abnormal_autonomic_nervous | 1.08489865 |
| 48 | MP0008961_abnormal_basal_metabolism | 1.05175497 |
| 49 | MP0005395_other_phenotype | 1.04649537 |
| 50 | MP0005551_abnormal_eye_electrophysiolog | 0.98235755 |
| 51 | MP0003638_abnormal_response/metabolism_ | 0.98196113 |
| 52 | MP0005084_abnormal_gallbladder_morpholo | 0.98040485 |
| 53 | MP0002063_abnormal_learning/memory/cond | 0.97990127 |
| 54 | MP0009785_altered_susceptibility_to | 0.97617507 |
| 55 | MP0005671_abnormal_response_to | 0.97350010 |
| 56 | MP0001186_pigmentation_phenotype | 0.97049406 |
| 57 | MP0000427_abnormal_hair_cycle | 0.92500476 |
| 58 | MP0003718_maternal_effect | 0.91295588 |
| 59 | MP0000428_abnormal_craniofacial_morphol | 0.88636190 |
| 60 | MP0005410_abnormal_fertilization | 0.88388655 |
| 61 | MP0003121_genomic_imprinting | 0.87836579 |
| 62 | MP0003635_abnormal_synaptic_transmissio | 0.87814075 |
| 63 | MP0002166_altered_tumor_susceptibility | 0.86656214 |
| 64 | MP0001944_abnormal_pancreas_morphology | 0.85842625 |
| 65 | MP0001188_hyperpigmentation | 0.85459016 |
| 66 | MP0002909_abnormal_adrenal_gland | 0.84509817 |
| 67 | MP0002064_seizures | 0.84023191 |
| 68 | MP0005646_abnormal_pituitary_gland | 0.82147473 |
| 69 | MP0002877_abnormal_melanocyte_morpholog | 0.80913933 |
| 70 | MP0001486_abnormal_startle_reflex | 0.80775374 |
| 71 | MP0010386_abnormal_urinary_bladder | 0.80285026 |
| 72 | MP0005636_abnormal_mineral_homeostasis | 0.78319219 |
| 73 | MP0005423_abnormal_somatic_nervous | 0.77429538 |
| 74 | MP0002733_abnormal_thermal_nociception | 0.76450560 |
| 75 | MP0003937_abnormal_limbs/digits/tail_de | 0.74914294 |
| 76 | MP0005187_abnormal_penis_morphology | 0.73855175 |
| 77 | MP0009840_abnormal_foam_cell | 0.73540398 |
| 78 | MP0005075_abnormal_melanosome_morpholog | 0.73384198 |
| 79 | MP0005310_abnormal_salivary_gland | 0.71072739 |
| 80 | MP0002102_abnormal_ear_morphology | 0.69829408 |
| 81 | MP0000470_abnormal_stomach_morphology | 0.69516169 |
| 82 | MP0001764_abnormal_homeostasis | 0.69268308 |
| 83 | MP0002098_abnormal_vibrissa_morphology | 0.69245161 |
| 84 | MP0003699_abnormal_female_reproductive | 0.69038931 |
| 85 | MP0001324_abnormal_eye_pigmentation | 0.68840159 |
| 86 | MP0005025_abnormal_response_to | 0.67967670 |
| 87 | MP0003942_abnormal_urinary_system | 0.64285910 |
| 88 | MP0003632_abnormal_nervous_system | 0.63102641 |
| 89 | MP0003866_abnormal_defecation | 0.60915583 |
| 90 | MP0002069_abnormal_eating/drinking_beha | 0.60430983 |
| 91 | MP0002229_neurodegeneration | 0.59733637 |
| 92 | MP0005266_abnormal_metabolism | 0.58839355 |
| 93 | MP0003119_abnormal_digestive_system | 0.58499071 |
| 94 | MP0008770_decreased_survivor_rate | 0.58135179 |
| 95 | MP0002210_abnormal_sex_determination | 0.57824724 |
| 96 | MP0002161_abnormal_fertility/fecundity | 0.57196636 |
| 97 | MP0000609_abnormal_liver_physiology | 0.56829107 |
| 98 | MP0004808_abnormal_hematopoietic_stem | 0.56669410 |
| 99 | MP0002723_abnormal_immune_serum | 0.56573834 |
| 100 | MP0003631_nervous_system_phenotype | 0.56011686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Action tremor (HP:0002345) | 8.40556271 |
| 2 | Genetic anticipation (HP:0003743) | 8.00015558 |
| 3 | Dysmetric saccades (HP:0000641) | 6.83514718 |
| 4 | Progressive cerebellar ataxia (HP:0002073) | 6.38443484 |
| 5 | Prostate neoplasm (HP:0100787) | 6.13061945 |
| 6 | Impaired proprioception (HP:0010831) | 4.68693069 |
| 7 | Retinal atrophy (HP:0001105) | 4.38278573 |
| 8 | Gaze-evoked nystagmus (HP:0000640) | 4.31819874 |
| 9 | Abnormality of the hepatic vasculature (HP:0006707) | 4.30677325 |
| 10 | Postural tremor (HP:0002174) | 4.21494568 |
| 11 | Abnormality of the prostate (HP:0008775) | 4.19358653 |
| 12 | Slow saccadic eye movements (HP:0000514) | 4.16639414 |
| 13 | Acute lymphatic leukemia (HP:0006721) | 4.15302946 |
| 14 | Absence seizures (HP:0002121) | 4.06651346 |
| 15 | Focal seizures (HP:0007359) | 3.72173354 |
| 16 | Hypothermia (HP:0002045) | 3.71475729 |
| 17 | Dialeptic seizures (HP:0011146) | 3.68379961 |
| 18 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.63155952 |
| 19 | Pendular nystagmus (HP:0012043) | 3.58780852 |
| 20 | Limb ataxia (HP:0002070) | 3.49792015 |
| 21 | Hyperventilation (HP:0002883) | 3.29173748 |
| 22 | Hypochromic microcytic anemia (HP:0004840) | 3.17455733 |
| 23 | Severe visual impairment (HP:0001141) | 3.09358464 |
| 24 | Slender build (HP:0001533) | 3.05051753 |
| 25 | Impaired vibratory sensation (HP:0002495) | 3.02487886 |
| 26 | Focal motor seizures (HP:0011153) | 2.87599015 |
| 27 | Postural instability (HP:0002172) | 2.87442910 |
| 28 | Dysdiadochokinesis (HP:0002075) | 2.77378094 |
| 29 | Abnormality of male internal genitalia (HP:0000022) | 2.76439379 |
| 30 | Diastasis recti (HP:0001540) | 2.55576368 |
| 31 | Bilateral microphthalmos (HP:0007633) | 2.51535978 |
| 32 | Abnormality of macular pigmentation (HP:0008002) | 2.49270826 |
| 33 | Gastrointestinal infarctions (HP:0005244) | 2.42495486 |
| 34 | Clumsiness (HP:0002312) | 2.38209832 |
| 35 | Cortical visual impairment (HP:0100704) | 2.36682302 |
| 36 | Impaired smooth pursuit (HP:0007772) | 2.36281596 |
| 37 | Atonic seizures (HP:0010819) | 2.32349510 |
| 38 | Poor suck (HP:0002033) | 2.30576697 |
| 39 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.29898325 |
| 40 | Rib fusion (HP:0000902) | 2.24415392 |
| 41 | Decreased testicular size (HP:0008734) | 2.23856257 |
| 42 | Insidious onset (HP:0003587) | 2.21975419 |
| 43 | Termporal pattern (HP:0011008) | 2.21975419 |
| 44 | Hypophosphatemic rickets (HP:0004912) | 2.20710592 |
| 45 | Short tibia (HP:0005736) | 2.14932776 |
| 46 | Status epilepticus (HP:0002133) | 2.13135765 |
| 47 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.09482078 |
| 48 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.09395052 |
| 49 | Loss of speech (HP:0002371) | 2.00596698 |
| 50 | Hypochromic anemia (HP:0001931) | 1.99774840 |
| 51 | Carpal bone hypoplasia (HP:0001498) | 1.98194990 |
| 52 | Ureteral obstruction (HP:0006000) | 1.95716167 |
| 53 | Depressed nasal tip (HP:0000437) | 1.95457158 |
| 54 | Spinal muscular atrophy (HP:0007269) | 1.95003901 |
| 55 | Pancreatic cysts (HP:0001737) | 1.94794962 |
| 56 | Congenital stationary night blindness (HP:0007642) | 1.94179084 |
| 57 | Hypoproteinemia (HP:0003075) | 1.93323406 |
| 58 | Decreased muscle mass (HP:0003199) | 1.93308640 |
| 59 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.93276820 |
| 60 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.91661374 |
| 61 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.91048472 |
| 62 | Hypogonadotrophic hypogonadism (HP:0000044) | 1.89318084 |
| 63 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.84472414 |
| 64 | Orthostatic hypotension (HP:0001278) | 1.84095309 |
| 65 | Spontaneous hematomas (HP:0007420) | 1.84095027 |
| 66 | Macroglossia (HP:0000158) | 1.82100550 |
| 67 | Abnormality of the sella turcica (HP:0002679) | 1.81352294 |
| 68 | Postnatal microcephaly (HP:0005484) | 1.79544457 |
| 69 | Fair hair (HP:0002286) | 1.78909728 |
| 70 | Periodontitis (HP:0000704) | 1.78420252 |
| 71 | Amaurosis fugax (HP:0100576) | 1.77956350 |
| 72 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.75735328 |
| 73 | Chest pain (HP:0100749) | 1.74492102 |
| 74 | Incomplete penetrance (HP:0003829) | 1.74270733 |
| 75 | Arterial thrombosis (HP:0004420) | 1.73269205 |
| 76 | Short humerus (HP:0005792) | 1.71529210 |
| 77 | Progressive sensorineural hearing impairment (HP:0000408) | 1.70443865 |
| 78 | Anorexia (HP:0002039) | 1.68581807 |
| 79 | Retinitis pigmentosa (HP:0000510) | 1.67614425 |
| 80 | Metaphyseal dysplasia (HP:0100255) | 1.65380852 |
| 81 | Progressive hearing impairment (HP:0001730) | 1.65155771 |
| 82 | J-shaped sella turcica (HP:0002680) | 1.64625377 |
| 83 | Abnormality of homocysteine metabolism (HP:0010919) | 1.62510396 |
| 84 | Homocystinuria (HP:0002156) | 1.62510396 |
| 85 | Abnormality of vision evoked potentials (HP:0000649) | 1.62137520 |
| 86 | Flat occiput (HP:0005469) | 1.61203254 |
| 87 | Attenuation of retinal blood vessels (HP:0007843) | 1.60814547 |
| 88 | Deformed sella turcica (HP:0002681) | 1.59320976 |
| 89 | Sensory axonal neuropathy (HP:0003390) | 1.58423704 |
| 90 | Portal hypertension (HP:0001409) | 1.57645047 |
| 91 | Microcytic anemia (HP:0001935) | 1.57611679 |
| 92 | Arthropathy (HP:0003040) | 1.56503183 |
| 93 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.56304557 |
| 94 | Breast aplasia (HP:0100783) | 1.54881069 |
| 95 | Gingival bleeding (HP:0000225) | 1.54653316 |
| 96 | Tented upper lip vermilion (HP:0010804) | 1.52793566 |
| 97 | Prominent supraorbital ridges (HP:0000336) | 1.52161444 |
| 98 | Oculomotor apraxia (HP:0000657) | 1.52047559 |
| 99 | Hypoplasia of the odontoid process (HP:0003311) | 1.51599255 |
| 100 | Papillary thyroid carcinoma (HP:0002895) | 1.50602096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK19 | 8.97973583 |
| 2 | OXSR1 | 4.54666104 |
| 3 | FRK | 3.67724115 |
| 4 | MKNK2 | 3.60660436 |
| 5 | MAP4K2 | 2.90276359 |
| 6 | TAOK1 | 2.62715561 |
| 7 | TAOK3 | 2.40196351 |
| 8 | SIK3 | 2.10284163 |
| 9 | MKNK1 | 1.92685167 |
| 10 | ADRBK2 | 1.88608279 |
| 11 | ALK | 1.79693448 |
| 12 | MARK1 | 1.69521539 |
| 13 | TLK1 | 1.69029825 |
| 14 | SCYL2 | 1.68792795 |
| 15 | ZAK | 1.67377873 |
| 16 | CSNK1G3 | 1.54944639 |
| 17 | PRKCG | 1.43389459 |
| 18 | SRPK1 | 1.41838721 |
| 19 | MAP4K1 | 1.37950166 |
| 20 | PRKCQ | 1.34461699 |
| 21 | CSNK1G2 | 1.34063955 |
| 22 | NTRK2 | 1.33501408 |
| 23 | CASK | 1.30344384 |
| 24 | MAPK15 | 1.25904618 |
| 25 | ERBB3 | 1.25674973 |
| 26 | WNK3 | 1.23260908 |
| 27 | GRK1 | 1.20158869 |
| 28 | SIK2 | 1.19444894 |
| 29 | MAP3K7 | 1.17890977 |
| 30 | TXK | 1.13789321 |
| 31 | CSNK1G1 | 1.04865392 |
| 32 | SGK1 | 1.04361405 |
| 33 | PNCK | 1.02836486 |
| 34 | FGR | 1.01021604 |
| 35 | TNK2 | 0.97608048 |
| 36 | LATS2 | 0.96223695 |
| 37 | MARK3 | 0.95276960 |
| 38 | RPS6KB2 | 0.94032922 |
| 39 | RPS6KA4 | 0.89958785 |
| 40 | ACVR1B | 0.89794812 |
| 41 | MAP3K11 | 0.89685510 |
| 42 | GRK6 | 0.88470065 |
| 43 | STK16 | 0.88201934 |
| 44 | MAPK13 | 0.83103614 |
| 45 | ERBB4 | 0.81907089 |
| 46 | MAP3K4 | 0.78314685 |
| 47 | MAP3K14 | 0.76434560 |
| 48 | MAP3K12 | 0.75697786 |
| 49 | WNK4 | 0.72326579 |
| 50 | PRKCE | 0.70954186 |
| 51 | PRKCZ | 0.70201492 |
| 52 | PTK2B | 0.58995535 |
| 53 | PDK2 | 0.56731359 |
| 54 | MAPKAPK5 | 0.56415025 |
| 55 | STK11 | 0.53842887 |
| 56 | SIK1 | 0.53801551 |
| 57 | CAMK4 | 0.53216973 |
| 58 | PKN1 | 0.52785972 |
| 59 | VRK1 | 0.49861750 |
| 60 | CHEK1 | 0.49000119 |
| 61 | CHEK2 | 0.46910509 |
| 62 | RPS6KA1 | 0.44087628 |
| 63 | MAP3K9 | 0.44006681 |
| 64 | FER | 0.42298397 |
| 65 | ERBB2 | 0.41364035 |
| 66 | CDK11A | 0.40711767 |
| 67 | STK3 | 0.39625618 |
| 68 | HIPK2 | 0.39049919 |
| 69 | PRKCD | 0.36411390 |
| 70 | STK24 | 0.36237687 |
| 71 | ITK | 0.35781145 |
| 72 | RPS6KA5 | 0.35305316 |
| 73 | MAPK10 | 0.33634860 |
| 74 | MAP2K2 | 0.33614599 |
| 75 | CDK15 | 0.33596860 |
| 76 | CDK14 | 0.32980613 |
| 77 | BTK | 0.31769001 |
| 78 | CDK18 | 0.30748029 |
| 79 | CSNK1A1 | 0.28461488 |
| 80 | IRAK3 | 0.28237286 |
| 81 | MAPK9 | 0.27589996 |
| 82 | CSNK1A1L | 0.26803265 |
| 83 | MAPK7 | 0.26355297 |
| 84 | MARK2 | 0.25191216 |
| 85 | CHUK | 0.24489422 |
| 86 | IKBKB | 0.23953635 |
| 87 | TGFBR2 | 0.23902897 |
| 88 | PRKG1 | 0.23851786 |
| 89 | JAK2 | 0.23832502 |
| 90 | CSF1R | 0.22782654 |
| 91 | CAMK2A | 0.22645335 |
| 92 | AKT1 | 0.21899633 |
| 93 | MTOR | 0.21737724 |
| 94 | MAP3K5 | 0.20758886 |
| 95 | RPS6KA2 | 0.20094659 |
| 96 | CDK7 | 0.19956708 |
| 97 | PLK3 | 0.19849301 |
| 98 | MAP3K1 | 0.19720632 |
| 99 | PRKD2 | 0.19377503 |
| 100 | PAK1 | 0.19126232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 5.94380696 |
| 2 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.47208955 |
| 3 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 3.02337090 |
| 4 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.62157143 |
| 5 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.38312109 |
| 6 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.27766672 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 2.06370560 |
| 8 | Sulfur relay system_Homo sapiens_hsa04122 | 1.96258292 |
| 9 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.95593817 |
| 10 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.82131154 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.63515874 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.62380301 |
| 13 | Long-term depression_Homo sapiens_hsa04730 | 1.61688797 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.55746415 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.53141095 |
| 16 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.51363432 |
| 17 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.49736941 |
| 18 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.47794668 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.47321265 |
| 20 | Olfactory transduction_Homo sapiens_hsa04740 | 1.46915347 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.45185926 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.43105840 |
| 23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.36873446 |
| 24 | RNA polymerase_Homo sapiens_hsa03020 | 1.35390021 |
| 25 | Alcoholism_Homo sapiens_hsa05034 | 1.32226654 |
| 26 | Phototransduction_Homo sapiens_hsa04744 | 1.26318853 |
| 27 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.24296281 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.20302788 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.16592741 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.14206040 |
| 31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.13149687 |
| 32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.12452114 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.09337379 |
| 34 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.06030145 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.05879681 |
| 36 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.05051095 |
| 37 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.04936383 |
| 38 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.01928147 |
| 39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.00589799 |
| 40 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.98599652 |
| 41 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.94622646 |
| 42 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.92838653 |
| 43 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.92134631 |
| 44 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.91086942 |
| 45 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.88532394 |
| 46 | Cocaine addiction_Homo sapiens_hsa05030 | 0.88066640 |
| 47 | Protein export_Homo sapiens_hsa03060 | 0.86653233 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 0.85912632 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.84944467 |
| 50 | Basal transcription factors_Homo sapiens_hsa03022 | 0.83818930 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80338133 |
| 52 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.79073306 |
| 53 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.78193836 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 0.77594723 |
| 55 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.73555090 |
| 56 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.73042151 |
| 57 | Gap junction_Homo sapiens_hsa04540 | 0.71420540 |
| 58 | Morphine addiction_Homo sapiens_hsa05032 | 0.71231775 |
| 59 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.70969176 |
| 60 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.69655793 |
| 61 | Renin secretion_Homo sapiens_hsa04924 | 0.69057806 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.63109872 |
| 63 | Circadian entrainment_Homo sapiens_hsa04713 | 0.60813990 |
| 64 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.60668840 |
| 65 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60406217 |
| 66 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59514974 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58961706 |
| 68 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58336857 |
| 69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.56834100 |
| 70 | Influenza A_Homo sapiens_hsa05164 | 0.55498384 |
| 71 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.54152190 |
| 72 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53951520 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53922501 |
| 74 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.53220948 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.51748969 |
| 76 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51451170 |
| 77 | Hepatitis C_Homo sapiens_hsa05160 | 0.50199200 |
| 78 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.49315267 |
| 79 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.48393062 |
| 80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48056129 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47724809 |
| 82 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.46749628 |
| 83 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.46089082 |
| 84 | GABAergic synapse_Homo sapiens_hsa04727 | 0.45563768 |
| 85 | Purine metabolism_Homo sapiens_hsa00230 | 0.44763860 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41525793 |
| 87 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.40765314 |
| 88 | RNA degradation_Homo sapiens_hsa03018 | 0.39076149 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37511131 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37482820 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36917638 |
| 92 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.36849126 |
| 93 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.36660135 |
| 94 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.33736994 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.33270293 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.33249384 |
| 97 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.31918300 |
| 98 | Circadian rhythm_Homo sapiens_hsa04710 | 0.31499517 |
| 99 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.31468935 |
| 100 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.31317975 |

